A fluorescence chemo sensor approach for determination of finerenone in pharmaceutical formulation and human plasma: Method development and validation
-
Published:2024-03
Issue:
Volume:309
Page:123836
-
ISSN:1386-1425
-
Container-title:Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
-
language:en
-
Short-container-title:Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Author:
Alsharif Shaker T.,
Alaqel Saleh l.,
Almalki Atiah H.,
Algarni Majed AORCID,
Alnemari Reem M.ORCID,
H.Abduljabbar Maram,
Abdelazim Ahmed H.
Reference7 articles.
1. The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction;Kintscher;Cardiovascular Diabetology,2023
2. Biotransformation of finerenone, a novel nonsteroidal mineralocorticoid receptor antagonist, in dogs, rats, and humans, in vivo and in vitro;Gerisch;Drug Metab. Dispos.,2018
3. Chemosensor and its applications;Rani;IRJRR,2015
4. Chemosensors based on molecularly imprinted polymers;Suriyanarayanan;Molecular Imprinting,2010
5. Determination of finerenone – a novel, selective, nonsteroidal mineralocorticoid receptor antagonist – in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study in venous and capillary human plasma
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献